表紙
市場調查報告書

神經調節:深部腦刺激及迷走神經刺激設備市場

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

出版商 Datamonitor Healthcare 商品編碼 939982
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
價格
神經調節:深部腦刺激及迷走神經刺激設備市場 Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market
出版日期: 2020年05月08日內容資訊: 英文 111 Pages
簡介

全球運動調節和癲癇治療的神經調節系統市場預計將從2019年的12億美元增長到2024年的18億美元,複合年增長率為8.5%。

本報告提供全球神經調節市場調查,提供臨床應用狀況,腦深層電刺激法(DBS)和迷走神經刺激療法(VNS)對應的技術,市場分析,相關企業的清單等資訊。

目錄

摘要整理

  • 合起了DBS和VNS的市場
    • 市場成長要素及阻礙因素
    • DBS市場
    • VNS市場
    • 市場領導者
  • 調查手法

第1章 臨床概要

  • DBS
  • VNS
  • 異動症
    • 帕金森氏症
    • 原發性顫抖症
    • 肌張力不全症
  • 癲癇
  • 重度憂鬱症
  • 神經病變的盛行率
  • 參考文獻

第2章 與DBS對應的技術

  • 主要的產品
    • Abbott
    • Boston Scientific
    • Medtronic
  • 參考文獻

第3章 VNS對應的技術

  • 主要的產品
    • LivaNova
    • Medtronic
    • NeuroPace
  • 參考文獻

第4章 市場分析

  • DBS設備市場
    • 市場預測: 世界
    • 市場預測:各地區
    • 成長促進因素及阻礙因素
    • 市場佔有率: 世界
    • 市場佔有率:各地區
  • VNS設備市場
    • 市場預測: 世界
    • 市場預測:各地區
    • 成長促進因素及阻礙因素
    • 市場佔有率: 世界
    • 市場佔有率:各地區
  • DBS和VNS的市場
  • 公司概要
    • Abbott
    • Boston Scientific
    • LivaNova
    • Medtronic
  • 參考文獻

附錄A:相關企業的清單

目錄
Product Code: #MDT20005

Overview

Global sales of neuromodulation systems for the treatment of movement disorders (Parkinson's disease, essential tremor, and dystonia) and epilepsy, which include implantable deep brain stimulation (DBS) and vagus nerve stimulation (VNS) devices, respectively, are expected to increase at a CAGR of approximately 8.5%, from nearly $1.2bn in 2019 to approximately $1.8bn in 2024. The highly competitive DBS and VNS segments-which contribute nearly one-third of the global $4.5bn+ neuromodulation market-are significantly underpenetrated, with substantial room for growth. The DBS/VNS markets are being driven by several positive factors, including: a long clinical history with a substantial reduction in debilitating symptoms, strong marketing and surgeon training efforts, and technological innovation (eg new directional lead technologies, precisely targeted stimulation, and therapy customization). The launch of next-generation DBS and VNS systems are further improving outcomes and providing patients with incurable neurological conditions a safe, effective, and long-term device-based therapy alternative.

The report provides the following useful information:

  • an overview of neuromodulation technology for the treatment of refractory neurological movement disorders and epilepsy
  • key epidemiology data on the prevalence of Parkinson's disease, essential tremor, dystonia, epilepsy, and depression
  • related product portfolios offered by leading manufacturers
  • top selling neuromodulation devices, as well as emerging products under development
  • in-depth market and competitive analyses.

Table of Contents

Executive Summary

  • i. Combined market
    • a. Selected market drivers and limiters
    • b. Deep brain stimulation devices segment
    • c. Vagus nerve stimulation devices segment
    • d. Market leaders
  • ii. Methodology
  • Exhibit ES-1: Deep brain stimulation and vagus nerve stimulation devices, combined market forecast ($m), by segment, 2019-24
  • Exhibit ES-2: Deep brain stimulation devices market, forecast sales by region ($m), 2019-24
  • Exhibit ES-3: Vagus nerve stimulation devices, forecast sales by region ($m), 2019-24

1. Clinical Overview

  • 1.1. Deep brain stimulation
  • 1.2. Vagus nerve stimulation
  • 1.3. Movement disorders
    • 1.3.1. Parkinson's disease
    • 1.3.2. Essential tremor
    • 1.3.3. Dystonia
  • 1.4. Epilepsy
  • 1.5. Major depressive disorder
  • 1.6. Prevalence of neurological disorders
  • 1.7. Bibliography
  • Exhibit 1-1: Diagram of Medtronic's deep brain stimulation system implantation
  • Exhibit 1-2: Diagram of vagus nerve stimulation therapy
  • Exhibit 1-3: Prevalence of movement disorders, epilepsy and depression

2. Deep Brain Stimulation Technology

  • 2.1. Selected products
    • 2.1.1. Abbott
    • 2.1.2. Boston Scientific
    • 2.1.3. Medtronic
  • 2.2. Bibliography
  • Exhibit 2-1: Implantable deep brain stimulation systems for movement disorders
  • Exhibit 2-2: Abbott's Infinity DBS system with proprietary directional leads
  • Exhibit 2-3: Boston Scientific's Vercise DBS portfolio, including new Vercise Gevia with Cartesia Directional Lead
  • Exhibit 2-4: Medtronic's Activa DBS systems
  • Exhibit 2-5: Medtronic's new Percept PC DBS system with BrainSense Technology
  • Exhibit 2-6: Medtronic DBS therapy indications

3. Vagus Nerve Stimulation Technology

  • 3.1. Selected products
    • 3.1.1. LivaNova
    • 3.1.2. Medtronic
    • 3.1.3. NeuroPace
  • 3.2. Bibliography
  • Exhibit 3-1: Vagus nerve stimulation using implantable VNS Therapy
  • Exhibit 3-2: Neuromodulation systems for the treatment of epilepsy
  • Exhibit 3-3: LivaNova's SenTiva VNS Therapy System
  • Exhibit 3-4: The anterior nucleus of the thalamus
  • Exhibit 3-5: The NeuroPace RNS System

4. Market Analysis

  • 4.1. Deep brain stimulation devices market
    • 4.1.1. Market forecast: global
    • 4.1.2. Market forecast: by region
    • 4.1.3. Market drivers and limiters
    • 4.1.4. Market share: global
    • 4.1.5. Market share: by region
  • 4.2. Vagus nerve stimulation devices market
    • 4.2.1. Market forecast: global
    • 4.2.2. Market forecast: by region
    • 4.2.3. Market drivers and limiters
    • 4.2.4. Market share: global
    • 4.2.5. Market share: by region
  • 4.3. Combined market
  • 4.4. Corporate profiles
    • 4.4.1. Abbott
    • 4.4.2. Boston Scientific
    • 4.4.3. LivaNova
    • 4.4.4. Medtronic
  • 4.5. Bibliography
  • Exhibit 4-1: Deep brain stimulation devices, global market forecast ($m), 2019-24
  • Exhibit 4-2: Deep brain stimulation devices market, estimated sales and share of revenues by region, 2019
  • Exhibit 4-3: Deep brain stimulation devices market, forecast sales by region ($m), 2019-24
  • Exhibit 4-4: Deep brain stimulation devices market, estimated global share by supplier, 2019
  • Exhibit 4-5: Selected noninvasive brain stimulation systems
  • Exhibit 4-6: Deep brain stimulation devices market ($m), estimated share by supplier and region, 2019
  • Exhibit 4-7: Vagus nerve stimulation devices, global market forecast ($m), 2019-24
  • Exhibit 4-8: Vagus nerve neurostimulation devices, estimated share of revenues by region, 2019
  • Exhibit 4-9: Vagus nerve stimulation devices, forecast sales by region ($m), 2019-24
  • Exhibit 4-10: Vagus nerve stimulation devices market, estimated global share by supplier, 2019
  • Exhibit 4-11: Vagus nerve stimulation devices market, estimated share by supplier and region, 2019
  • Exhibit 4-12: Combined deep brain stimulation and vagus nerve stimulation devices market, forecast sales by segment ($m), 2019-24
  • Exhibit 4-13: Abbott, revenues by segment, FY2019
  • Exhibit 4-14: Boston Scientific, revenues by segment, FY2019
  • Exhibit 4-15: LivaNova, revenues by segment, FY2019
  • Exhibit 4-16: Medtronic, revenues by segment, FY2019

Appendix A: company listing